Funding Briefs

p.21 In fiscal 1992, the National Institutes of Health plans to spend $13 million to help stimulate research at small colleges and universities that traditionally have not been supported by NIH funding. Since 1985, NIH has offered Academic Research Enhancement Awards (AREA grants) to support new research projects or help expand ongoing research efforts by faculty undergraduate institutions. These funds are for projects related to the health sciences. To be eligible for AREA grants, an institut

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

p.21 In fiscal 1992, the National Institutes of Health plans to spend $13 million to help stimulate research at small colleges and universities that traditionally have not been supported by NIH funding. Since 1985, NIH has offered Academic Research Enhancement Awards (AREA grants) to support new research projects or help expand ongoing research efforts by faculty undergraduate institutions. These funds are for projects related to the health sciences.

To be eligible for AREA grants, an institution must not have received an NIH Biomedical Research Support Grant of more than $20,000, and the principal investigator must not have active NIH or Alcohol, Drug Abuse, and Mental Health Administration support at the time of the application. Funding decisions are based on the scientific merit of the proposal and on the institution's contribution to the undergraduate training of doctoral-level health professionals. Preference is given to colleges that have graduated 25 or more students ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies